Loading the records…
Loading the records…
This $14.2M CDC contract for adult vaccines underscores continued federal investment in public health. While the recipient is not matched to a publicly traded company in our records, the contract supports the broader healthcare sector, particularly vaccine manufacturers and distributors. Related legislative efforts to expand Medicare coverage and advance clinical development could further boost demand for adult vaccines.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
This contract reinforces the stable demand for adult vaccines within the federal healthcare budget. While no specific publicly traded company is directly linked, the entire vaccine ecosystem—including manufacturers, distributors, and logistics providers—benefits from continued government procurement. Legislative efforts to expand Medicare coverage and accelerate clinical development could provide additional tailwinds, supporting sector-wide growth in vaccine-related revenues.
The Department of Health and Human Services, through the Centers for Disease Control and Prevention, awarded a $14.2M indefinite delivery/indefinite quantity contract to GLAXOSMITHKLINE, LLC for the Vaccines for Adults program (EO 14398). This contract covers the period from July 2026 to June 2027 and is part of the federal government's ongoing commitment to adult immunization. The recipient entity is not identified as a publicly traded company in our database, so no direct stock impact can be attributed to a specific ticker.
Without a public parent company, the contract's market impact is best understood at the sector level. The award signals stable government demand for adult vaccines, benefiting the entire vaccine supply chain—from manufacturers and distributors to healthcare providers. Companies involved in vaccine production, such as those producing influenza, pneumococcal, or shingles vaccines, may see indirect benefits from sustained procurement levels.
Several legislative proposals in the current session align with the objectives of this contract. HR10875, which would lower Medicare eligibility to age 50, could expand the insured population for adult vaccines. HR10874 aims to improve low-income subsidy access under Medicare, potentially increasing vaccine uptake. HR10857 seeks to accelerate clinical development of novel treatments, including vaccines, which could enhance future product pipelines. S5684 focuses on contractor accountability, which may influence how future vaccine contracts are managed.
While no specific supply chain partners are named in this contract, typical beneficiaries of CDC vaccine awards include large pharmaceutical distributors, cold-chain logistics providers, and public health infrastructure vendors. These entities often see steady revenue from government immunization programs, though the impact of a single $14.2M award is modest relative to their overall business.
Historically, CDC vaccine contracts provide predictable, multi-year revenue streams for the healthcare sector. Similar awards have supported consistent investment in vaccine research and manufacturing capacity. For investors, the key takeaway is that federal immunization programs remain a reliable source of demand, and legislative tailwinds could amplify this effect over time.
Matched on shared policy language across AI analyses, with ticker & timing weight
GLAXOSMITHKLINE, LLC: $733M Department of Health and Human Services Contract Vehicle
PFIZER INC: $769M Department of Health and Human Services Contract Vehicle
SANOFI VACCINES US INC.: $580M Department of Health and Human Services Contract Vehicle
MERCK SHARP & DOHME LLC: $2.0B Department of Health and Human Services Contract Vehicle
Executive orders & memoranda affecting the same sectors or companies
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Recipient
GLAXOSMITHKLINE, LLC
Award Amount
$14,237,955
Awarding Agency
Department of Health and Human Services
Sub-Agency
Centers for Disease Control and Prevention
Contract Type
INDEFINITE DELIVERY / INDEFINITE QUANTITY
Related Bills
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →